Removal of Antibiotic Cement-Coated Interlocking Nails.


Journal

Journal of orthopaedic trauma
ISSN: 1531-2291
Titre abrégé: J Orthop Trauma
Pays: United States
ID NLM: 8807705

Informations de publication

Date de publication:
01 06 2022
Historique:
accepted: 07 10 2021
pubmed: 16 10 2021
medline: 18 6 2022
entrez: 15 10 2021
Statut: ppublish

Résumé

To report the outcomes of antibiotic cement-coated interlocking nail (ACCIN) removal, detail a removal technique that mitigates debonding of coating, and describe how to address occurrences intraoperatively. Retrospective case series. Level II trauma center. Twenty-eight patients who underwent ACCIN removal between January 2014 and August 2019. Removal of ACCINs that were coated using the silicone tubing method. Successful removal of the nail with intact antibiotic coating. A total of 42 ACCIN removals were included in this study. Successful ACCIN removal was achieved in 37 cases (88.1%), with debonding in only 5 cases (11.9%). Eight nails (19%) required 1 additional removal procedure, and 3 nails (7.1%) required 2 additional removal procedures. The main reasons for the additional procedures were nonunion and persistent infection. ACCIN insertion and removal can be challenging. The proper technique of coating and insertion can facilitate later removal. Removal of knee-long fusion rods can be more challenging. Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.

Identifiants

pubmed: 34653105
doi: 10.1097/BOT.0000000000002287
pii: 00005131-202206000-00008
doi:

Substances chimiques

Anti-Bacterial Agents 0
Bone Cements 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

317-320

Informations de copyright

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

No funding was received for this study. J.D. Conway is a consultant for Zimmer Biomet, Bonesupport, and Smith+Nephew and receives fellowship support from Biocomposites. The spouse of J.D. Conway receives royalties from the University of Florida. The remaining authors report no conflict of interest. The following organizations supported institution #1: Biocomposites, DePuy Synthes Companies, MHE Coalition, Orthofix, OrthoPediatrics, Pega Medical, Smith+Nephew, Stryker, and Zimmer Biomet.

Références

Barger J, Fragomen AT, Rozbruch SR. Antibiotic-coated interlocking intramedullary nail for the treatment of long-bone osteomyelitis. JBJS Rev. 2017;5:e5.
Conway J, Mansour J, Kotze K, et al. Antibiotic cement-coated rods: an effective treatment for infected long bones and prosthetic joint nonunions. Bone Joint J. 2014;96-B:1349–1354.
Antoci V, Phillips MJ, Antoci V Jr, et al. The treatment of recurrent chronic infected knee arthroplasty with a 2-stage procedure. J Arthroplasty. 2009;24:e13–e17.
Antoci V, Phillips MJ, Antoci V Jr, et al. Using an antibiotic-impregnated cement rod-spacer in the treatment of infected total knee arthroplasty. Am J Orthop. 2009;38:31–33.
Bengtson S, Knutson K. The infected knee arthroplasty. A 6-year follow-up of 357 cases. Acta Orthop Scand. 1991;62:301–311.
Castelli CC, Gotti V, Ferrari R. Two-stage treatment of infected total knee arthroplasty: two to thirteen year experience using an articulating preformed spacer. Int Orthop. 2014;38:405–412.
Gülabi D, Erdem M, Ceçen GS. Treatment of chronic osteomyelitis of the femur with combined technique. Eklem Hast Cerrahisi. 2014;25:173–178.
Pawar A, Dikmen G, Fragomen A, et al. Antibiotic-coated nail for fusion of infected charcot ankles. Foot Ankle Int. 2013;34:80–84.
Wood JH, Conway JD. Advanced concepts in knee arthrodesis. World J Orthop. 2015;6:202–210.
Thonse R, Conway JD. Antibiotic cement-coated nails for the treatment of infected nonunions and segmental bone defects. J Bone Joint Surg. 2008;90(suppl 4):163–174.
Askew MJ, Kufel MF, Fleissner Jr PR, et al. Effect of vacuum mixing on the mechanical properties of antibiotic-impregnated polymethylmethacrylate bone cement. J Biomed Mater Res. 1990;24:573–580.
Bhadra AK, Roberts CS. Indications for antibiotic cement nails. J Orthop Trauma. 2009;23:S26–S30.
Mendicino RW, Bowers CA, Catanzariti AR. Antibiotic-coated intramedullary rod. J Foot Ankle Surg. 2009;48:104–110.
Reilly RM, Robertson T, O'Toole RV, et al. Are antibiotic nails effective in the treatment of infected tibial fractures? Injury. 2016;47:2809–2815.
Sancineto CF, Barla JD. Treatment of long bone osteomyelitis with a mechanically stable intramedullar antibiotic dispenser: nineteen consecutive cases with a minimum of 12 months follow-up. J Trauma. 2008;65:1416–1420.
Shyam AK, Sancheti PK, Patel SK, et al. Use of antibiotic cement-impregnated intramedullary nail in treatment of infected non-union of long bones. Indian J Orthop. 2009;43(4):396–402.
Lowe JA, Vosburg C, Murtha YM, et al. A new technique for removing intramedullary cement. J Orthop Trauma. 2011;25(12):762–766.
Buehler KO, Walker RH. Polymethylmethacrylate removal from the femur using a crescentic window technique. Orthopedics. 1998;21(6):697–700.
Porsch M, Schmidt J. Cement removal with an endoscopically controlled ballistically driven chiselling system. A new device for cement removal and preliminary clinical results. Arch Orthop Trauma Surg. 2001;121(5):274-277.
Zweymüller KA, Steindl M, Melmer T. Anterior windowing of the femur diaphysis for cement removal in revision surgery. Clin Orthop Relat Res. 2005;441:227–236.

Auteurs

Talal B Abalkhail (TB)

International Center for Limb Lengthening, Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore, Baltimore, MD; and.
Department of Orthopedics, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.

Ahmed H Elhessy (AH)

International Center for Limb Lengthening, Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore, Baltimore, MD; and.

Janet D Conway (JD)

International Center for Limb Lengthening, Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore, Baltimore, MD; and.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH